company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25914238000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25914238000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11422046000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11422046000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14492192000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7407998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2505649000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9913647000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4578545000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,593142000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,634768000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-150523000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-108897000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4469648000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,863334000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3606314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3606314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3606314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1543082000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1560057000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.31
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1541200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29527552000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29527552000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12612022000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12612022000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16915530000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8435624000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2786067000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11221691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5693839000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,528474000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,320226000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,370695000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,162447000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5856286000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1122070000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4734216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,146503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4880719000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4880719000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545355000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.16
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1560753000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.12
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1544500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.16
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7497660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7497660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3352869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3352869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4144791000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2067914000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,680360000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2748274000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1396517000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,125014000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55313000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,46220000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23481000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1373036000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,288424000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1084612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1084612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1084612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545639000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1563730000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1549400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 10:45:41+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7314021000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7314021000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3119700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3119700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4194321000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2052317000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,735419000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2787736000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1406585000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,137769000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,295999000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,229733000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1636318000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,314304000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1322014000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1322014000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1322014000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1539786000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1553395000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,768600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 09:27:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30764707000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30764707000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13209329000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13209329000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17555378000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8405904000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2913733000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11319637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6235741000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,519656000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,137779000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1339910000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,958033000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7193774000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1447936000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5745838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5745838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5745838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1546983000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.71
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1555126000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.69
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1548700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.71
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8790127000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8790127000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3784223000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3784223000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5005904000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2225047000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,917048000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3142095000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1863809000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,123885000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29445000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53513000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-40927000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1822882000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,284153000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1538729000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1538729000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1538729000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1546983000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1555126000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.99
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1548700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.2
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7761336000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7761336000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3360187000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3360187000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4401149000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2085660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,675736000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2761396000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1639753000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,134612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,327821000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,231622000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1871375000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,391008000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1480367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1480367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1480367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1546291000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1552483000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.95
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1558300000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 13:50:38+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21974580000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21974580000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9425106000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9425106000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12549474000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6180857000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1996685000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8177542000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4371932000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,395771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,108334000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1286397000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,998960000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5370892000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1163783000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4207109000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4207109000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4207109000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1546291000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.71
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1552483000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.7
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1558300000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.71
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.2
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7494876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7494876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3128998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3128998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4365878000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2024252000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,670206000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2694458000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1671420000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,136969000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33877000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1290000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-104382000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1567038000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,278933000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1288105000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1288105000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1288105000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545643000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1550564000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1551900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:33:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14213244000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14213244000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6064919000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6064919000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8148325000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4095197000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1320949000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5416146000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2732179000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261159000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69921000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,958576000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,767338000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3499517000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,772775000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2726742000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2726742000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2726742000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545643000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.76
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1550564000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.75
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1551900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.76
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6718368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6718368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2935921000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2935921000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3782447000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2070945000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,650743000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2721688000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1060759000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,124190000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36044000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,959866000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,871720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1932479000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,493842000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1438637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1438637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1438637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545767000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1556385000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.92
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1546900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35166721000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35166721000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14665192000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14665192000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20501529000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10376324000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4037624000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14413948000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6087581000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,374747000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-374747000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5712834000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1086662000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4626172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4626172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4626172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1546400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1556022000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1552400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9967848000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9967848000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4045040000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4045040000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5922808000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2797229000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1295632000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4092861000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1829947000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2487000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16257000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-75887000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-62117000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1767830000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,326983000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1546400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1556022000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1552400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-2.15
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8674505000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8674505000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3741116000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3741116000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4933389000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2673277000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1078927000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3752204000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1181185000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,149102000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15590000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16437000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-117075000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1064110000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173450000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,890660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,890660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,890660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1554052000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1535600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 14:00:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25198873000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25198873000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10620152000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10620152000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14578721000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7579095000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2741992000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10321087000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4257634000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,372260000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-16257000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75887000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-312630000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3945004000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,759679000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3185325000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3185325000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3185325000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1554052000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.05
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1535600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.15
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33989000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33989000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14404375000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14404375000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19584625000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9804142000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3659040000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13463182000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6121443000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,496145000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13188000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,129400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-353557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5767886000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1043832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4724054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4724054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4724054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1545413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1554052000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1535600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.95
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8826014000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8826014000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3543932000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3543932000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5282082000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2743418000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,932698000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3676116000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1605966000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,134488000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49037000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-47279000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1558687000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,267037000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1291650000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1291650000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1291650000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1544415000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1551782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1556200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 15:04:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16524368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16524368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6879036000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6879036000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9645332000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4905818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1663065000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6568883000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3076449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,223158000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,59450000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-195555000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2880894000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,586229000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2294665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2294665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2294665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1544415000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1551782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1556200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.71
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33075831000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33075831000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14023446000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14023446000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19052385000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9216525000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3255849000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12472374000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6580011000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,481655000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36011000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,440784000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4860000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6575151000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1261390000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5313761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5313761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5313761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1544415000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.43
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1551782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.42
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1556200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.43
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7698354000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7698354000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3335104000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3335104000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4363250000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2162400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,730367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2892767000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1470483000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,88670000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-70019000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-148276000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1322207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,319192000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1003015000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1003015000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1003015000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1547815000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1561323000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29403000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31744693000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31744693000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13608512000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13608512000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18136181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8497359000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2993357000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11490716000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6645465000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,484136000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31716000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,390457000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61963000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6583502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1273286000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5310216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5310216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5310216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1547815000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.43
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1561323000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.42
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29403000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.43
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38851259000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38851259000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15540580000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15540580000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23310679000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12756817000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4801914000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17558731000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5751948000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,530141000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,85196000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-108361000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-553306000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5198642000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,470193000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1557643000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.03
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1567389000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.01
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1560500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.03
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10377453000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10377453000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3837875000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3837875000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6539578000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2905503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1551607000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4457110000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2082468000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,126086000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23796000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26473000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-128763000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1953705000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,335037000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3109781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1557643000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1567389000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1560500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.44
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9816665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9816665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3973250000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3973250000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5843415000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4238910000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1009627000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5248537000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,594878000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,124339000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20816000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10240000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-93283000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,501595000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,198414000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-303181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1558556000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1568287000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 14:04:37+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28473806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28473806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11702705000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11702705000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16771101000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9851314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3250307000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13101621000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3669480000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,404055000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81888000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-424543000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3244937000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135156000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3109781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1558556000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1568287000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.97
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.44
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38441654000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38441654000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15747745000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15747745000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22693909000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12648543000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4545939000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17194482000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5499427000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,406542000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77657000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-157775000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-486660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5012767000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,462139000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3109781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1558556000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1568287000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.9
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.71
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9616291000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9616291000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3870472000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3870472000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5745819000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2762086000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1210280000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3972366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1773453000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,134129000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18868000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16364000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-98897000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1674556000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-268226000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1942782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1556869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1566103000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 14:37:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18657141000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18657141000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7729455000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7729455000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10927686000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5612404000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2240680000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7853084000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3074602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,279716000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40584000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-92128000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-331260000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2743342000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-63258000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2806600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1556869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1566103000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.78
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.96
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37299494000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37299494000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15515611000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15515611000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21783883000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11082910000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4615239000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15698149000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6085734000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,431305000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72431000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-151578000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-510452000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5575282000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,437175000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2806600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2331507000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2331507000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2331507000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1556869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1566103000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.75
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9040850000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9040850000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3858983000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3858983000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5181867000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2850318000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1030400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3880718000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1301149000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,145587000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21716000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-108492000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-232363000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1068786000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,204968000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-863818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1551755000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1558641000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36509217000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36509217000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15189071000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15189071000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21320146000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11064242000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4337657000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15401899000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5918247000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,431664000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,91735000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-118905000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-458834000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5459413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,972438000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-863818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3623157000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3623157000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3623157000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1551755000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.89
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1558641000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.88
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.89
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19050000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19050000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8899000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8899000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6735000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1461000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,595000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8791000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1360000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1671000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,59000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-220000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-457000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,237000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,5726000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5963000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5963000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1575000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.76
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1592000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1585900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.76
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.67
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3188231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3188231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1680867000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1680867000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1507364000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1159230000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,376028000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-4502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1530756000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23392000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1353598000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-40020000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1420799000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1444191000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-580214000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-863977000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1917435000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1053458000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1053458000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1575000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1592000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1585900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5264787000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5264787000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2488913000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2488913000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2775874000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1920115000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,350653000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,195089000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2465857000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,310017000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,152034000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63865000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9463000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-78706000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,231311000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-107610000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,338921000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1603885000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1942806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1942806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1576771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1594279000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.21
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1592500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:05:51+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15861769000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15861769000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7218133000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7218133000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8643636000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5575770000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1084972000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,599502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7260244000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1383392000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,317402000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,99020000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,59181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-159201000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1224191000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,123214000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1100977000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3808565000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4909542000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4909542000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1576771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.1
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1594279000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.07
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1592500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.1
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26239222000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26239222000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11056008000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11056008000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15183214000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8481273000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2636579000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,599502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11717354000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3465860000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,443488000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,122816000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32708000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-287964000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3177896000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,458251000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3109781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5829426000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3808565000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9637991000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9637991000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1576771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.14
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1594279000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.11
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1592500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.14
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.09
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5313297000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5313297000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2370056000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2370056000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2943241000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1813623000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,370605000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,194823000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2379051000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,564190000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,83288000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18889000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29713000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34686000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,529504000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,118663000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,410841000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1313771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1724612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1724612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1572099000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1588502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.08
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1582200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:33:40+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10596982000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10596982000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4729220000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4729220000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5867762000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3655655000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,734319000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,404413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4794387000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1073375000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,165368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35155000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49718000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-80495000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,992880000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,230824000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,762056000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2204680000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2966736000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2966736000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1572099000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.88
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1588502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.86
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1582200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.88
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.02
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30791100000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30791100000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12540345000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12540345000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18250755000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10800068000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3295553000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,404413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14500034000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3750721000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,415793000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79767000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,33485000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-302541000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3448180000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,764275000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2806600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5490505000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2204680000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7695185000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7695185000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1572099000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.11
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1588502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.09
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1582200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.11
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5283685000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5283685000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2359164000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2359164000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2924521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1842032000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,363714000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,209590000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2415336000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,509185000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,82080000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16266000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20005000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45809000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,463376000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,112161000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,351215000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,890909000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1242124000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1242124000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1573921000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.79
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1589510000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1572300000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.79
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35094094000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35094094000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14040761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14040761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21053333000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11748531000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4135228000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,209590000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16093349000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4959984000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,466634000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79746000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20136000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-366752000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4593232000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,377386000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,863818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5079664000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,890909000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5970573000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5970573000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1573921000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1589510000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1572300000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.03
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19657000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19657000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9193000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9193000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10464000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6372000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1371000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,588000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8331000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2133000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,145000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,67000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-92000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2041000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,53000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1988000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,588000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1558000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1570700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4008000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4008000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1961000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1961000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2047000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1260000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,323000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,46000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1629000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,418000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,405000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,324000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,266000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,590000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,590000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1558000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1570700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15649000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15649000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7232000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7232000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8417000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5112000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1048000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,542000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,118000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1636000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1664000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,322000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1986000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1986000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1551803000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1566691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1558100000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18837231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18837231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8912867000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8912867000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9924364000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6271230000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1424028000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,537498000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8232756000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1691608000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1471598000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7980000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-36181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1499799000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,191809000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-608214000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,800023000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2239435000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3039458000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3039458000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1551803000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.93
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1566691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.9
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1558100000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.93
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4825000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4825000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2255000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2255000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1612000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,339000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2097000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,473000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,481000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-163000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,644000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,322000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,966000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,966000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1551803000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1566691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1558100000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:01:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10824000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10824000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4977000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4977000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5847000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,709000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4605000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1242000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-87000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1155000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1020000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1020000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1020000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1560519000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1576684000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1586700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19277018000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19277018000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9146780000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9146780000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10130238000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6579345000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1435681000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,586587000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8601613000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1528625000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1586632000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55845000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-55718000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1586505000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57880000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-552824000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,494944000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3521320000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4016264000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4016264000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1560519000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1576684000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.5
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1586700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.93
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5446000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5446000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2545000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2545000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2901000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,363000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2274000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,627000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,17000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,601000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,125000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1560519000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1576684000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1586700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:32:05+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5378000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5378000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2946000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1786000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,346000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2331000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,554000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1568730000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1586018000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1554300000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19144315000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19144315000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8971836000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8971836000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10172479000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6678968000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1443286000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,584410000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8706664000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1465815000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1629920000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,57734000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23005000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1595191000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-129376000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-559161000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,429785000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,4835091000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5264876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5264876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1568730000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1586018000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1554300000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20247000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20247000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11029000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6530000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1345000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,555000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8430000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2599000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,168000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2518000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,797000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1721000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,563000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2284000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2284000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1516000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1527000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.49
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1522700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.9
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5356000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5356000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3019000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1666000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,361000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,163000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2190000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,829000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,61000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,804000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,634000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,271000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,905000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,905000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1516000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1527000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1522700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5079000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5079000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2319000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2319000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2760000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1595000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,305000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,132000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2032000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,728000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,277000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,438000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,538000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,538000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1508596000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1519780000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1494400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 14:37:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14891000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14891000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6881000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6881000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8010000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4864000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,984000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,392000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6240000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1770000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,107000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-56000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,627000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1087000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1379000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1379000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1508596000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1519780000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1494400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.66
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18899000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18899000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8842000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8842000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10057000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6124000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1307000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,438000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7869000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,134000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-69000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2119000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,708000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1411000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,558000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1508596000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1519780000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1494400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.88
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5057000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5057000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2288000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2288000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2769000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1649000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,310000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,133000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2092000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,677000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,658000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,233000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,425000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,41000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1506595000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1517046000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1503200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:28:00+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9812000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9812000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4562000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4562000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5250000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3269000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,679000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,260000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4208000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1042000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,72000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,999000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,350000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,649000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,192000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,841000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,841000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1506595000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1517046000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1503200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18645000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18645000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8778000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8778000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9867000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6141000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1341000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,452000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7934000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1933000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,136000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1885000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,268000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1617000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,780000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2397000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2397000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1506595000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1517046000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1503200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4755000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4755000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2274000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2274000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2481000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1620000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,369000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,127000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2116000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,365000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,341000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,117000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,224000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1532810000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1547691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1562500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19034000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19034000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9035000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9035000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9999000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6206000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1394000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,516000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8116000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1883000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-55000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1668000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,739000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2407000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2407000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1532810000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1547691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1562500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20405000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20405000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8747000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8747000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11658000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6785000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1405000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,601000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8791000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2867000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,163000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,374000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,316000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,577000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2606000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1817000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4423000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4423000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1496000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1506000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.92
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1504400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2206000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2206000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2982000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1655000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,369000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2167000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,815000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,830000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,695000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,72000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,767000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,767000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1496000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1506000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1504400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2242000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2242000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2908000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1666000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,378000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,713000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,118000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,596000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1495465000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1505167000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1487200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:26:45+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15217000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15217000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6541000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6541000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8676000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5130000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1036000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,458000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6624000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2052000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,122000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,350000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,301000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2353000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,442000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1911000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1745000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1495465000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.43
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1505167000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.41
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1487200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.43
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20573000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20573000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8878000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8878000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11695000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6796000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1397000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,621000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8814000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2881000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,362000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,276000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3157000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,612000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2545000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2016000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4561000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4561000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1495465000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.02
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1505167000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1487200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.02
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.96
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2952000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1727000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,345000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2223000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,729000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,44000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,274000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,257000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,986000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,786000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,784000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,784000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1493771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1504215000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:32:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10067000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10067000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4299000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4299000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5768000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3464000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,658000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,307000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4429000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1339000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1639000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,324000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1315000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1761000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1493771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1504215000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.03
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20502000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20502000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8955000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8955000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11547000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6725000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1324000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,602000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8651000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2896000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,177000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,90000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,349000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,262000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3158000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,771000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2387000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2132000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1493771000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.99
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1504215000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.99
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4897000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4897000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2081000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2081000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2816000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1737000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,313000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,156000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2206000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,610000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,59000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,653000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,124000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,529000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1763000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1504995000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1515537000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20389000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20389000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9025000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9025000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11364000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6647000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1289000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,584000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2844000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,169000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2830000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,804000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2026000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2175000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1504995000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.78
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1515537000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.76
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1507900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.78
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.92
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20853000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20853000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9094000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9094000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11759000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6736000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3026000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,431000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,99000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1281000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1613000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1413000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,350000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1063000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1400000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1400000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1489400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.045
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2382000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2382000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2951000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1673000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,121000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2162000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,789000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,153000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,215000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,86000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,875000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,110000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,765000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,33000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1489400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5302000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5302000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2285000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2285000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3017000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1628000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,352000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2120000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,897000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,117000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-981000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-179000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,178000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-357000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1476366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1476366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1495500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:18:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6712000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6712000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8808000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5063000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1079000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,429000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6571000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2237000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,278000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,75000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1496000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1699000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,538000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,240000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,298000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,304000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,602000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,602000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1476366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1476366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1495500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.78
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20708000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20708000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8918000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8918000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11790000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6718000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,572000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8738000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3052000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,319000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,107000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1472000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1684000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,993000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,376000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1369000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1369000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1476366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1476366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1495500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.04
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2287000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2287000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3046000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1737000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,348000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,145000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2230000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,816000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,116000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,599000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1474504000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1480492000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:39+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4427000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4427000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5791000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3435000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,727000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,289000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4451000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1340000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,161000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-515000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-623000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,717000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,62000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,655000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,276000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,931000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,931000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1474504000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1480492000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20556000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20556000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8875000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8875000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11681000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6756000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1474000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,583000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8813000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2868000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,243000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-474000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-607000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2261000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,315000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1946000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,332000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2278000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2278000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1474504000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1480492000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.52
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.02
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4885000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4885000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2745000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1698000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,379000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,144000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2221000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,524000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,58000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-497000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-522000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-54000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,260000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,316000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,316000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1477332000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483673000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1504800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20393000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20393000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8806000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8806000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11587000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6746000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1471000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8806000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2781000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,184000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,117000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-182000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-249000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2532000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,399000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2133000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,314000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1477332000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483673000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1504800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27390000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27390000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12409000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12409000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14981000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9182000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2260000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1975000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13417000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1564000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,124000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,667000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2231000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1878000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,353000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,124000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1749000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1766700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3282000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3282000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4307000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,619000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,560000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,651000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,246000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,134000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-77000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1438000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-864000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1749000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1766700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.8
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6829000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6829000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2876000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2876000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3953000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2115000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,568000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,501000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3184000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,769000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,626000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,65000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,561000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,42000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,603000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,603000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1743757000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1754156000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1773500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:02:08+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.265
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19801000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19801000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9127000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9127000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10674000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6705000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1641000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1415000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9761000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,913000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,658000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,89000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1313000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,744000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1657000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,440000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1217000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,88000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1305000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1305000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1743757000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1754156000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1773500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25134000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25134000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11509000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11509000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13625000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8378000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2009000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1536000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11923000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,811000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1528000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,830000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2532000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1982000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,121000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1743757000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1754156000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1773500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6637000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6637000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3189000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3189000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,392000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3062000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,386000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,214000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,92000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-91000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,295000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,270000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,283000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,283000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1740524000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1748883000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1768800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:02:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.265
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12972000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12972000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6251000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6251000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6721000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4590000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1073000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,914000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6577000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,144000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,440000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1274000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,887000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1031000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,46000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1740524000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1748883000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1768800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23607000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23607000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10918000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10918000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12689000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7891000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1793000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1175000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10859000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1830000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,710000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,99000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,508000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1727000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,663000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1064000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,107000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1740524000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1748883000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1768800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3062000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3062000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3273000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2440000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,553000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,522000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3515000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-242000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,226000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1182000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,978000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,736000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,350000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,386000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,33000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,419000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,419000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1727356000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1735195000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1745800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.265
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10016000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10016000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12287000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7478000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1621000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,928000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10027000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2260000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,599000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,88000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,398000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-113000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2147000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,754000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1393000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,110000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1503000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1503000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1727356000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.97
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1735195000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1745800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.97
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.05
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30578000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30578000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12706000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12706000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17872000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9744000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2300000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2178000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14222000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3650000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,993000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,111000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-777000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2873000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,539000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2334000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,34000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1758000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1770000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1767200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7765000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7765000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3191000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3191000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2359000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,562000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,488000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3409000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1165000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,272000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,947000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,655000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,654000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,654000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1758000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1770000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1767200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4490000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2377000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3495000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,995000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,270000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-29000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-277000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,718000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,552000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,11000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,563000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,563000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1759585000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1771680000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1759400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:02:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22813000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22813000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9515000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9515000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13298000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7385000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1738000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1690000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10813000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,721000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,91000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-559000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1926000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,247000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1679000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1759585000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1771680000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.96
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1759400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12797000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12797000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17605000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9862000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2357000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2250000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14469000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3136000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,967000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,106000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,225000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-636000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1685000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,815000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,71000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,886000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,886000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1759585000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1771680000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1759400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7767000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7767000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3282000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3282000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,575000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,562000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3603000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,882000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,210000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,84000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-105000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,777000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,59000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,718000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1757836000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1768950000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1745200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 16:15:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15157000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15157000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6349000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6349000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8808000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5008000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1164000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7318000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1490000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,451000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,120000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-282000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1208000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1127000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1757836000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1768950000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1745200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29575000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29575000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12507000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12507000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17068000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9600000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2351000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2207000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14158000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2910000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,915000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,120000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,293000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-502000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2408000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1584000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,824000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,102000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,926000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,926000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1757836000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1768950000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1745200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.03
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7390000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7390000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3067000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3067000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4323000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2542000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,584000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,608000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,241000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-177000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,431000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,409000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,9000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,418000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,418000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1753412000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1765278000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1741700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28445000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28445000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12414000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12414000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16031000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9284000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2296000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2037000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13617000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2414000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,919000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,130000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,301000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-488000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1926000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,376000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1753412000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1765278000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1741700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.02
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8314000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8314000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3434000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3434000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4880000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2413000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,595000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3491000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1389000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,227000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-149000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1240000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1049000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1049000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1049000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1781000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1781200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13231000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13231000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18673000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9765000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2440000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14141000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4532000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,94000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,184000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-455000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4077000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,390000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3687000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3687000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3687000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.07
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1781000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1781200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.07
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23590000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23590000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9797000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9797000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13793000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7352000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1845000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1453000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10650000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,506000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,131000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-306000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2837000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1771521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1784167000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1777800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31355000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31355000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12988000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12988000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9711000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2407000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1941000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14059000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4308000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,778000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-524000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3784000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,491000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3293000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1771521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1784167000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.84
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1777800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3358000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3358000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4718000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2440000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,596000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,484000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1198000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,167000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-95000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,960000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,960000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,960000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1771521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1784167000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1777800000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:02:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15514000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15514000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6439000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6439000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9075000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4912000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1249000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7130000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1945000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,339000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,83000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-211000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1734000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1678000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1678000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1678000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768904000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1781417000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1764900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30935000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30935000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12796000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12796000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9648000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2385000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2001000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14034000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4105000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,881000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,101000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,74000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-706000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3399000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,514000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2885000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,10000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2895000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2895000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768904000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1781417000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.63
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1764900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.24
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7979000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7979000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3279000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3279000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4700000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2434000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,577000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3494000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1206000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,168000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-104000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1102000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1006000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1006000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1006000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768904000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1781417000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1764900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 16:15:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7535000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7535000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2478000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,672000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,486000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3636000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,739000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,41000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-107000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,632000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-40000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,672000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,672000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,672000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1763278000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1776573000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1768400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30723000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30723000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12799000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12799000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17924000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9680000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2383000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2080000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3781000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,923000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,116000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-707000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3074000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2597000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2622000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2622000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1763278000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1776573000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1768400000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.48
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.28
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32095000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32095000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13352000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13352000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18743000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9835000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2346000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2011000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14192000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4551000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,701000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,89000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-473000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4078000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3559000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,20000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3579000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3579000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768901000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.01
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1780578000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.99
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1762500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.01
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7726000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7726000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3281000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3281000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4445000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2548000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,578000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,561000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3687000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,758000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-125000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,633000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,89000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,20000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,564000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,564000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1768901000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1780578000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1762500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
